Lung cancer in never smokers — a different disease
Sophie Sun, Joan H. Schiller, Adi F. Gazdar · Nature reviews. Cancer · 2007
Cited by 1,608 works. doi:10.1038/nrc2190
Authors
References
- Global cancer statistics
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
- Global Cancer Statistics, 2002
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
- Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
- Somatic mutations affect key pathways in lung adenocarcinoma
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
- Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
- Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)